AU2012905406A0 - Sublingual and buccal delivery of tocotrienol derivatives as therapeutic agents - Google Patents

Sublingual and buccal delivery of tocotrienol derivatives as therapeutic agents

Info

Publication number
AU2012905406A0
AU2012905406A0 AU2012905406A AU2012905406A AU2012905406A0 AU 2012905406 A0 AU2012905406 A0 AU 2012905406A0 AU 2012905406 A AU2012905406 A AU 2012905406A AU 2012905406 A AU2012905406 A AU 2012905406A AU 2012905406 A0 AU2012905406 A0 AU 2012905406A0
Authority
AU
Australia
Prior art keywords
sublingual
therapeutic agents
buccal delivery
tocotrienol derivatives
tocotrienol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2012905406A
Inventor
Glenn Tong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GORDAGEN PHARMACEUTICALS Pty Ltd
Original Assignee
GORDAGEN PHARMACEUTICALS Pty Ltd
Filing date
Publication date
Application filed by GORDAGEN PHARMACEUTICALS Pty Ltd filed Critical GORDAGEN PHARMACEUTICALS Pty Ltd
Publication of AU2012905406A0 publication Critical patent/AU2012905406A0/en
Priority to RU2015120181A priority Critical patent/RU2015120181A/en
Priority to US14/435,607 priority patent/US10675265B2/en
Priority to EP13854440.8A priority patent/EP2919777B1/en
Priority to ES13854440T priority patent/ES2778065T3/en
Priority to CA2891164A priority patent/CA2891164C/en
Priority to SG11201503640WA priority patent/SG11201503640WA/en
Priority to KR1020147022626A priority patent/KR20150082109A/en
Priority to CN201380022566.8A priority patent/CN104582700B/en
Priority to DK13854440.8T priority patent/DK2919777T3/en
Priority to NZ628963A priority patent/NZ628963A/en
Priority to MYPI2015000856A priority patent/MY177940A/en
Priority to PCT/AU2013/001310 priority patent/WO2014075135A1/en
Priority to JP2015540965A priority patent/JP6460998B2/en
Priority to PL13854440T priority patent/PL2919777T3/en
Priority to BR112015010703-6A priority patent/BR112015010703B1/en
Priority to CN202011457257.1A priority patent/CN112451518A/en
Priority to PE2015000622A priority patent/PE20151518A1/en
Priority to AU2013344817A priority patent/AU2013344817B2/en
Priority to PT138544408T priority patent/PT2919777T/en
Priority to IL238727A priority patent/IL238727A0/en
Priority to IN4006DEN2015 priority patent/IN2015DN04006A/en
Priority to PH12015501048A priority patent/PH12015501048A1/en
Priority to ZA2015/04191A priority patent/ZA201504191B/en
Priority to HK15107895.4A priority patent/HK1207295A1/en
Priority to JP2018177662A priority patent/JP6978392B2/en
Priority to US15/929,297 priority patent/US11331302B2/en
Priority to JP2020171008A priority patent/JP2021008509A/en
Abandoned legal-status Critical Current

Links

AU2012905406A 2012-11-13 2012-12-11 Sublingual and buccal delivery of tocotrienol derivatives as therapeutic agents Abandoned AU2012905406A0 (en)

Priority Applications (27)

Application Number Priority Date Filing Date Title
PL13854440T PL2919777T3 (en) 2012-11-13 2013-11-13 Transmucosal delivery of tocotrienol
JP2015540965A JP6460998B2 (en) 2012-11-13 2013-11-13 Transmucosal delivery of tocotrienol
BR112015010703-6A BR112015010703B1 (en) 2012-11-13 2013-11-13 use of a pharmaceutical composition and pharmaceutical composition
EP13854440.8A EP2919777B1 (en) 2012-11-13 2013-11-13 Transmucosal delivery of tocotrienol
ES13854440T ES2778065T3 (en) 2012-11-13 2013-11-13 Transmucosal administration of tocotrienol
CA2891164A CA2891164C (en) 2012-11-13 2013-11-13 Transmucosal delivery of tocotrienol
SG11201503640WA SG11201503640WA (en) 2012-11-13 2013-11-13 Transmucosal delivery of tocotrienol
KR1020147022626A KR20150082109A (en) 2012-11-13 2013-11-13 Transmucosal delivery of tocotrienol
CN201380022566.8A CN104582700B (en) 2012-11-13 2013-11-13 Transmucosal delivery of tocotrienols
DK13854440.8T DK2919777T3 (en) 2012-11-13 2013-11-13 TRANSMUKOSAL RELEASE OF TOCOTRIENOL
US14/435,607 US10675265B2 (en) 2012-11-13 2013-11-13 Transmucosal delivery of tocotrienol
MYPI2015000856A MY177940A (en) 2012-11-13 2013-11-13 Transmucosal delivery of tocotrienol
PCT/AU2013/001310 WO2014075135A1 (en) 2012-11-13 2013-11-13 Transmucosal delivery of tocotrienol
RU2015120181A RU2015120181A (en) 2012-11-13 2013-11-13 Transmucosal delivery of tocotrienol
NZ628963A NZ628963A (en) 2012-11-13 2013-11-13 Transmucosal delivery of tocotrienol
PT138544408T PT2919777T (en) 2012-11-13 2013-11-13 Transmucosal delivery of tocotrienol
CN202011457257.1A CN112451518A (en) 2012-11-13 2013-11-13 Transmucosal delivery of tocotrienols
PE2015000622A PE20151518A1 (en) 2012-11-13 2013-11-13 TRANSMUCOSE ADMINISTRATION OF TOCOTRIENOL
AU2013344817A AU2013344817B2 (en) 2012-11-13 2013-11-13 Transmucosal delivery of tocotrienol
IL238727A IL238727A0 (en) 2012-11-13 2015-05-10 Transmucosal delivery of tocotrienol
IN4006DEN2015 IN2015DN04006A (en) 2012-11-13 2015-05-11
PH12015501048A PH12015501048A1 (en) 2012-11-13 2015-05-11 Transmucosal delivery of tocotrienol
ZA2015/04191A ZA201504191B (en) 2012-11-13 2015-06-10 Transmucosal delivery of tocotrienol
HK15107895.4A HK1207295A1 (en) 2012-11-13 2015-08-14 Transmucosal delivery of tocotrienol
JP2018177662A JP6978392B2 (en) 2012-11-13 2018-09-21 Transmucosal delivery of tocotrienols
US15/929,297 US11331302B2 (en) 2012-11-13 2020-04-23 Transmucosal delivery of tocotrienol
JP2020171008A JP2021008509A (en) 2012-11-13 2020-10-09 Transmucosal delivery of tocotrienol

Publications (1)

Publication Number Publication Date
AU2012905406A0 true AU2012905406A0 (en) 2013-01-10

Family

ID=

Similar Documents

Publication Publication Date Title
EP2890780B8 (en) Methods and compositions for treatment of a genetic condition
IL237581B (en) Derivatives of 6-oxo-pyrazinopyrrolopyrimidines
HK1186737A1 (en) Derivatives of azaindazole or diazaindazole type as medicament
ZA201204959B (en) Pyrazole derivatives as jak inhibitors
IL229963A (en) Substituted quinolines and their use as medicaments
FI3156056T3 (en) Pharmaceutical compositions comprising sorbitan esters
HK1207295A1 (en) Transmucosal delivery of tocotrienol
SG10201505752QA (en) Use of proanthocyanidin b2 for preparing medicaments
HK1214523A1 (en) Transmucosal delivery of glatiramer acetate
HK1188791A1 (en) Novel octahydrothienoquinoline derivative, pharmaceutical composition comprising derivative, and use of these
HK1214522A1 (en) Oral transmucosal delivery of glatiramer acetate
AU2012905406A0 (en) Sublingual and buccal delivery of tocotrienol derivatives as therapeutic agents
AU2012904937A0 (en) Sublingual and buccal delivery of tocotrienol derivatives as therapeutic agents
AU2012903646A0 (en) Therapeutic methods and compositions
AU2012901350A0 (en) Therapeutic methods and compositions
AU2011903938A0 (en) Therapeutic methods and compositions
GB201108673D0 (en) Colour stability of dual medicament dressings
EP2785722A4 (en) Tocotrienol derivatives and associated methods
AU2011901447A0 (en) Prophylactic and therapeutic compositions
AU2011900644A0 (en) Therapeutic Uses of SLIRP
AU2012903850A0 (en) Use of enantiomers of perhexiline
AU2011900519A0 (en) Drug compositions for the treatment of insomnia